Connect with us

Health

NAFDAC intensifies tracking mechanism to curb narcotic abuse

Published

on

The National Agency for Food and Drug Administration and Control (NAFDAC) has disclosed that it is intensifying its efforts in developing tracking mechanisms from the pictures of production to curb substance abuse.

The agency in a statement on Sunday said it has put in place effective mechanisms to track and trace narcotic products right from the very source of production, the manufacturing plant, to the end user, the patient through narcotic drugs serialisation.

Prof Adeyeye noted that narcotics were chosen amongst other classes of drugs to make sure that we do not have drug or substance abuse in Nigeria or to mitigate it, adding that this will be replicated for all other NAFDAC-regulated drug products.

Going down memory lane, Prof Adeyeye recalled the ubiquitous misuse of Tramadol and Codeine all over the country when she got to NAFDAC in 2017 with their adverse effects on the mental health of young adults, children, and women that were selling codeine or tramadol.

“For the first six months of my tenure, I was running after tramadol or codeine because at that time,” she said
As a regulatory Agency saddled with the responsibility of ensuring the safety and quality of medicines, she stated that NAFDAC places utmost importance on good distribution practices as a core mandate of the agency is to ensure that the distribution of medical products along the pharmaceutical supply chain reflects best global practices.

She however regretted that one of the greatest challenges that we face today in the healthcare sector is the occurrence of substandard and falsified medicines.

She added that in Nigeria, this problem is further compounded by the chaotic drug distribution practices of unscrupulous elements of society who do not place a premium on human lives.

“These are the sharp practices that the Traceability project (Track and Trace) seeks to stop,” she maintained as she enthused that “Track and Trace (Traceability) is indeed a game changer.”

With this technology, she said medicines can now be tracked and traced right from the very source of production, the manufacturing plant, to the end user, the patient.

Through the scanning device on an Android phone, the NAFDAC boss said consumers can now verify the authenticity of the drug product they consume and be assured of the quality of medicines. More importantly, she said the track and trace technology is a veritable tool to be deployed in the event of medication recalls.

“The commissioning event of the project is a crystallization of a series of activities that the Agency embarked upon since May 2018, when we attended the very first GS1 Africa healthcare conference in Addis Ababa, Ethiopia. This led to the development and formulation of the Traceability Strategy Document, a five-year implementation roadmap for pharmaceutical products that was launched by the then Honourable Minister for Health in October 2020.”.

She said the narcotic drugs serialisation pilot project symbolises a significant milestone in the Agency’s commitment to delivering quality, efficacious, and easily verifiable medical products to the Nigerian consumer by adequately securing the drug distribution network.
She explained that the need to commence the track and trace of pharmaceutical products with narcotic medicines is a very strategic one, noting that Narcotic drugs occupy a very prime place in healthcare, and due to the very high propensity for abuse and diversion of this group of essential medicines cannot always be overruled.
The DG disclosed that the pilot project will be on for about one year, during which “we expect to have been familiar with all that will be necessary to enhance the deployment and full implementation of the track and trace project for other drug classes in scalable phases.”
Prof Adeyeye further stated that manufacturers must first commission the products they are registered to distribute into the NAFDAC Traceability System, and when it gets to the distributors or the wholesalers, they will also scan the products using a 2D Data Matrix barcode scanner to capture the event related to the movement of the product.

The NAFDAC boss said that all this will be captured in the Agency’s Information Traceability System so that if something goes off the track within the supply chain it would be easily traced and tracked and help in no small measure to reduce drug abuse.

The Managing Director of the technical partner, GS1 Nigeria, Mr. Tunde Odunlami, described the occasion as a very significant day in the history of traceability in Nigeria.

For GS1, he said that it has been a journey that started over ten years ago when the company started preaching the importance of traceability. He, however, commended NAFDAC for identifying the importance of this standard in transforming the way we do things in the country and enabling traceability and a good distribution system for the country.

“NAFDAC has taken the mantle as you can see today where we are now doing serialization of a very important class of medication which is Narcotics,” he said, as he explained the GSI standard and the role it will play in the system.
Mr. Odunlami further explained that GS1 provided the standard while Newsoft Nigeria Plc is the solution provider saddled with the responsibility of developing the solution and carrying out the implementation.

Health

Assembly passes Kano Pre-Marital Health Screening Bill

Published

on

Kano State House of Assembly has passed a bill for a law to compel intending couples to undergo HIV, hepatitis and sickle cell anaemia screening before marriage.

The passage followed deliberations in the Committee of the Whole House during plenary session,
presided over by the Speaker, Ismail Falgore on Monday in Kano.

After deliberations, the lawmakers approved the 3rd reading of the bill, read by the Deputy Clerk, Alhaji Nasiru Magaji.

Shortly after passage of the bill, the Majority Leader of the house, Lawan Hussein (NNPP-Dala), stated that “any person
intending to marry shall first submit self for medical examinations.”

He said the bill was considered and passed after the 3rd reading, following various legislative processes.

The leader further said that the bill was passed because the state had been battling with different health issues, including
HIV because people go into marriages without medical screening.

He said that the bill, if signed into law, would save many lives and curb the spread of life-threatening diseases.

“The bill will safeguard the health of citizens by institutionalising pre-marital testing to check the spread of diseases
like hepatitis, HIV and sickle cell anaemia,” he added.

Continue Reading

Health

WHO to begin vaccination against Human Papilloma Virus May 27 in Kogi

Published

on

The World Health Organisation (WHO), says it plans to commence vaccination against Human Papilloma Virus (HPV) on May 27 in Kogi.

The state’s Team Lead of WHO, Dr Muktar Toyosi, said this when he led his team on an advocacy visit to the State Council of the Nigeria Union of Journalists (NUJ) on Wednesday in Lokoja.

Toyosi said that the vaccination was meant for girl child of between the age nine and 14.

He said the ongoing sensitisation was to keep the people informed, and educate them on the vaccination of their children to protect them against cervical cancer in future.

”Kogi falls within the second phase of the programme. We are soliciting for the cooperation of the media in educating the people of the state on the HPV vaccination.

“There need for girls child across the state to take the vaccination to safeguard their future.

“Although the vaccine was initially scarce and difficult to get, the good news now is that it has been made available by the government,” Toyosi said.

Also speaking, the State Technical Assistant for WHO, Dr Ahmed Attah, said that the HPV mostly affect women, adding that the vaccination remained a preventive measure against the disease.

Attah, a former state Chairman of the Nigeria Medical Association (NMA) and a former Chief Medical Director (CMD), Kogi Specialist Hospital (KSSH) Lokoja, urged parents and guardians to avail their children of the vaccination to justify government’s investment.

In his response, the Kogi NUJ Chairman, Mr Seidu Ademu, described the health sector as very critical, stressing that the vaccination was a right step in the right direction.

Ademu promised a robust partnership with WHO to enable the team to achieve its set goals.
He stressed the need to inform, educate and sensitise the general public on the need to embrace the vaccine by ensuring that girls within the age range were vaccinated.

Continue Reading

Health

NCDs will be leading cause of mortality in Africa by 2030 – WHO

Published

on

The World Health Organisation (WHO) says Non-communicable Diseases (NCDs) will become the leading cause of mortality in Africa by 2030 if urgent measures are not executed by member states.

Dr Matshidiso Moeti, WHO Regional Director for Africa, joining virtually, made the assertion on Tuesday at the opening of the first International Conference on PEN-Plus in Africa (ICPPA 2024) in Dar es Salaam, Tanzania.

The ICPPA 2024, holding from April 23 to April 25, is aimed at addressing severe NCDs in Africa.

It is being hosted by the WHO Regional Office for Africa, Helmsley Charitable Trust, and the United Republic of Tanzania. Moeti urged member states to embrace strategies that would help to address the issue.

“We are faced with non-communicable diseases and data from low and middle income countries show that 26 per cent of total health spending was due to NCDs, second only to infectious and parasitic diseases.

“Meaning it is urgent to give these often overlooked diseases priority attention as Africa is severely affected and more than in any other place in the world.

“The surge in the burden of NCDs on our continent over the past two decades, is driven by increasing incidences of risk factors, such as unhealthy diets, reduced physical activity, obesity, and air pollution.

“NCDs are set to overtake communicable, maternal, neonatal and nutritional diseases combined as a leading cause of mortality in Africa by 2030.

“And here, the NCDs are called silent epidemics. Unfortunately, this rapid devolution, with a higher mortality rate has not been recognised in the region, because we’re not investing adequately in detecting and lowering the burden of these diseases,” Moeti said.

Moeti noted that severe NCDs like type one diabetes, rheumatic heart disease, and sickle cell disease more frequently affect children and young adults in the majority of Africans population.

She advised that Africa must show increased commitment in addressing NCDs with adequate and sustained resources.

She also said there was the need to strengthen accountability and assess the impact of interventions by enhancing surveillance and monitoring.

According to Moeti, this can be achieved using reliable and timely data at national and sub national levels to drive policy and action as we move forward.

Ms Elke Wisch, UNICEF Representative to Republic of Tanzania, said that collaboration was at the heart of collective response to tackling NCDs.

“Today’s gathering underscores the urgency and importance of addressing NCDs comprehensively and collaboratively.

“The WHO package of essential non communicable  interventions for PEN, for primary healthcare and low resources settings, and the recently launched regional strategy on PEN-Plus provides a strategic framework  for tackling NCDs at their roots,” she said.

Also speaking, Ummy Mwalimu, Minister of Health, Tanzania, said that non communicable diseases NCDs, have become a formidable threat to the health and wellbeing of “our people.”

She urged for collective efforts to address these threats.

“They are silently affecting the lives of our citizens, our communities, undermining the progress we strive to achieve as a nation.

“The impact of these diseases extends beyond individual suffering.

“It affects our communities, our economy, and ultimately the future of our nations in our continent.

“Yet, in the face of these challenges, we are not discouraged together. We have chosen to confront these non-communicable diseases.’’

She urged for lifestyle change as positive way to combatting the negative outcomes of NCDs.

James Reid, Programme Officer for the Helmsley Charitable Trust’s Type 1 Diabetes (T1D) Programme, said he was happy at the level of interest and momentum in engagements to address NCDs, especially Type 2 diabetes.

He, however, identified finance as one of the biggest challenge and hindrance. He said that while political leaders and stakeholders identify the challenges that NCDs pose, the strategies to prevent them, especially NCD care, were limited.

“Leadership for driving of PEN-Plus is very important to make sure that ministry of health leaders and all others involved, really understand how to change the dynamics as well as adopt solutions to suit specific localities,” she said.

WHO’s PEN-Plus (Package of Essential NCD-Plus), is a regional integrated care delivery strategy to address severe non-communicable diseases at first-level referral health facilities.

At the 2022 WHO Regional Committee Meeting for the African Region, the 47 Member States of the AFRO region voted to adopt the PEN-Plus strategy.

It is focused on alleviating the burden among the poorest children and young adults. This is by increasing the accessibility and quality of chronic care services for severe NCDs including Type 1 diabetes, rheumatic heart disease, and sickle cell disease.

 ICPPA 2024 provides opportunity to shore up international support for scaling up PEN-Plus in the African Region. Also, the conference serves as a platform to raise awareness of severe NCDs, share lessons from countries implementing PEN-Plus and identify opportunities to strengthen NCD management.

Continue Reading

Trending